Effectiveness of Triamcinolone and Hyaluronidase in Alleviation of Clinical Spectrum in Patients with Oral Sub Mucous Fibrosis

Introduction:The following study has discussed the efficacy of triamcinolone and hyaluronidase as well as its improvement in clinical features.Fibrosis of the tissue, precancerous lesions, and scarring of the tissue is caused by a persistent condition known as oral submucous fibrosis (OSMF) where buccal mucosa is the most prominent site to be affected. Methods:The department of Otorhinolaryngology in our institution carried out a study in which sixty individuals were given injections of triamcinolone and hyaluronidase to determine the effectiveness of the drugs in treating OSMF.The study was carried out on patients who had already been diagnosed with OSMF. Results:The bulk of the patients were ranging between 20 to 30 years with the majority falling into the former category.In comparison to the number of females, there was a preponderance of males.48.3% of patients had symptoms for a period of less than a year.45 percent of patients showed an increase in interincisal distance of between 1 and 5 millimeters, whereas 31 percent of patients showed no change in the distance.By the end of the 12-week follow-up period, 95% of patients showed significant improvement in mouth opening, 96.7% showed a reduction in the burning sensation, 93.3% showed a reduction in the blanching of the mucosa, and 81.7% showed a reduction in the amount of ulceration. Conclusion:The study concludes that there is reduction in all the presenting symptoms of OSMF on treatment with triamcinolone and hyaluronidase.Moreover, statistical analysis has obtained more effective outcomes.